Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-17-001716
Filing Date
2017-02-22
Accepted
2017-02-22 16:29:08
Documents
40
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO QUARTERLY REPORT f10q0616a1_americanbrivision.htm 10-Q/A 323705
2 CERTIFICATION f10q0616a1ex31i_americanbri.htm EX-31.1 10808
3 CERTIFICATION f10q0616a1ex31ii_americanbri.htm EX-31.2 11421
4 CERTIFICATION f10q0616a1ex32i_americanbri.htm EX-32.1 4055
5 CERTIFICATION f10q0616a1ex32ii_americanbri.htm EX-32.2 4160
  Complete submission text file 0001213900-17-001716.txt   1520270

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20160630.xml EX-101.INS 188759
7 XBRL SCHEMA FILE mtoo-20160630.xsd EX-101.SCH 19987
8 XBRL CALCULATION FILE mtoo-20160630_cal.xml EX-101.CAL 21533
9 XBRL DEFINITION FILE mtoo-20160630_def.xml EX-101.DEF 32624
10 XBRL LABEL FILE mtoo-20160630_lab.xml EX-101.LAB 138758
11 XBRL PRESENTATION FILE mtoo-20160630_pre.xml EX-101.PRE 103848
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-91436 | Film No.: 17628824
SIC: 2834 Pharmaceutical Preparations